lexatumumab
mapatumumab
panitumumab
conatumumab
oleclumab
patritumab
tenatumomab
tigatuzumab
sibrotuzumab
acrixolimab
duligotuzumab
inotuzumab
drozitumab
matuzumab
dalotuzumab
figitumumab
lintuzumab
naptumomab estafenatox
inotuzumab ozogamicin
onartuzumab
pamrevlumab
iratumumab
nofetumomab
dacetuzumab
samalizumab
agonistic monoclonal antibody
adecatumumab
pritumumab
avelumab
teprotumumab
brentuximab
durvalumab
lucatumumab
carlumab
cergutuzumab
ertumaxomab
catumaxomab
apolizumab
bivatuzumab
alacizumab
oportuzumab monatox
sonepcizumab
teplizumab
dorlixizumab
elotuzumab
tucotuzumab
cixutumumab
ocrelizumab
ramucirumab
intetumumab